Student perceptions of the utility of the Pharmacy Curriculum Outcomes Assessment.


Journal

Currents in pharmacy teaching & learning
ISSN: 1877-1300
Titre abrégé: Curr Pharm Teach Learn
Pays: United States
ID NLM: 101560815

Informations de publication

Date de publication:
03 2020
Historique:
received: 22 05 2019
revised: 16 08 2019
accepted: 04 12 2019
entrez: 11 4 2020
pubmed: 11 4 2020
medline: 6 5 2021
Statut: ppublish

Résumé

This study assessed student perceptions, preparation, and result use strategies of the Pharmacy Curriculum Outcomes Assessment (PCOA). Secondarily, it studied the effect of schools/colleges of pharmacy (S/COP) PCOA management on student perceptions. A 52-item electronic questionnaire assessed PCOA preparation of final year students, review/use of results, remediation participation, self-reported motivation, and perceptions of the exam's ability to measure PCOA blueprint areas and North American Pharmacy Licensure Examination (NAPLEX)/advanced pharmacy practice experience (APPE) readiness. Programs were given a questionnaire to determine their PCOA practices. The student survey was completed by 341 students (40% response rate). Students prepared very little for the PCOA and few reported participation in PCOA-based remediation (6%). Students perceived the PCOA to measure the four domains moderately well, although administrative sciences were significantly lower. Students reported less confidence in the exam's ability to measure APPE/NAPLEX-readiness. Although few used the PCOA to guide their NAPLEX preparation (18%), they were more likely to do so than for APPEs (4%). Students reported a higher perceived increase in motivation if PCOA results were connected to APPE placement, remediation, and progression as opposed to prizes, rewards, or other recognitions. This is the first multi-institutional study to review student perceptions about the PCOA. These data can be used along with other PCOA data to help schools develop incentive, remediation, and examination administration procedures depending on the programs desired use for the PCOA exam.

Identifiants

pubmed: 32273060
pii: S1877-1297(19)30254-0
doi: 10.1016/j.cptl.2019.12.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

255-264

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None.

Auteurs

Mike Rudolph (M)

University of Kentucky, Lexington, KY, United States.

Justine S Gortney (JS)

Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, United States.

Angela Brownfield (A)

University of Missouri-Kansas City School of Pharmacy at MU, Columbia, MO, United States.

David Caldwell (D)

Department of Pharmacy Practice, University of Arkansas College of Pharmacy, Little Rock, AR, United States.

Ashley Castleberry (A)

The University of Texas at Austin College of Pharmacy, Austin, TX, United States.

Uyen Minh Le (UM)

California Northstate University College of Pharmacy, Elk Grove, CA, United States.

Melissa S Medina (MS)

Department of Pharmacy: Clinical and Administrative Sciences, The University of Oklahoma Health Sciences Center College of Pharmacy, Oklahoma City, OK, United States.

Julie M Sease (JM)

University of South Carolina College of Pharmacy, Columbia, SC, United States.

Jennifer Trujillo (J)

University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, United States.

Adam C Welch (AC)

Bill Gatton College of Pharmacy, East Tennessee State University, Johnson City, TN, United States.

Kimberly K Daugherty (KK)

Sullivan University College of Pharmacy and Health Sciences, 2100 Gardiner Lane, Louisville, KY 40205, United States. Electronic address: kdaugherty@sullivan.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH